Synaptopathy and Noise-Induced Hearing Loss

Patient Tools

Read, save, and share this guide

Use these quick tools to make this medical article easier to read, print, save, or share with a family member.

Synaptopathy and Noise-Induced Hearing Loss

Article Summary

Recent animal studies have revealed substantial irreversible neural degeneration following the temporary noise-induced elevation of the auditory threshold, i.e., temporary threshold shift (TTS).  Despite no hair cell loss and recovery of threshold sensitivity, exposed animals demonstrated extensive loss of synaptic connections between cochlear hair cells and auditory nerve terminals and delayed degeneration of spiral ganglion cells and their central projections  (Kujawa and Liberman, 2009; Lin,...

Key Takeaways

  • This article explains Participants in simple medical language.
  • This article explains Pre-Workshop Discussions in simple medical language.
  • This article explains Workshop Format in simple medical language.
  • This article explains Workshop Recommendations in simple medical language.
Educational health guideWritten for patient understanding and clinical awareness.
Reviewed content workflowUse writer and reviewer profiles for stronger trust.
Emergency safety firstUrgent warning signs are highlighted below.

Seek urgent medical care if you notice

These warning signs are general safety guidance. Local emergency numbers and clinical judgment should always come first.

  • Severe symptoms, breathing difficulty, fainting, confusion, or rapidly worsening illness.
  • New weakness, severe pain, high fever, or symptoms after a serious injury.
  • Any symptom that feels urgent, unusual, or unsafe for the patient.
1

Emergency now

Use emergency care for severe, sudden, rapidly worsening, or life-threatening symptoms.

2

See a doctor

Book a professional medical evaluation if symptoms persist, worsen, recur often, affect daily activities, or occur in a high-risk patient.

3

Learn safely

Use this article to understand possible causes, tests, treatment options, prevention, and questions to ask your clinician.

Recent animal studies have revealed substantial irreversible neural degeneration following the temporary noise-induced elevation of the auditory threshold, i.e., temporary threshold shift (TTS).  Despite no hair cell loss and recovery of threshold sensitivity, exposed animals demonstrated extensive loss of synaptic connections between cochlear hair cells and auditory nerve terminals and delayed degeneration of spiral ganglion cells and their central projections  (Kujawa and Liberman, 2009; Lin, et al., 2011; for review, Kujawa and Liberman, 2015). Single-unit recordings indicate that high-threshold auditory nerve fibers with lower spontaneous rates are preferentially lost under these conditions (Furman, et al., 2013), suggesting that this type of noise-induced damage could negatively impact the ability to process supra-threshold sounds, especially in the presence of masking noise, though a loss would not likely be detected using threshold audiometry (for review, Plack, et al., 2014).

The focus of this NIDCD workshop was to identify barriers to, and opportunities in, the area of noise-induced synaptopathy and to articulate unmet research needs as the scientific community looks to translate these animal studies into the realm of the human auditory system and the clinic.

Participants

The workshop was organized by Janet Cyr, Ph.D., and Amy Donahue, Ph.D., in the NIDCD Division of Scientific Programs and co-chaired by Sharon Kujawa, Ph.D., and M. Charles Liberman, Ph.D., from Massachusetts Eye and Ear Infirmary/Harvard Medical School. Drs. Kujawa and Liberman moderated the meeting and discussions.

Sixteen auditory scientists from the U.S. and abroad were invited to bring their expertise to the discussion (see participant list). Two invited participants, Alice Suter, Ph.D., and Rick Davis, Ph.D., were unable to attend the face-to-face meeting but were involved in pre-workshop discussions. In addition, Dan Tagle, Ph.D., from the NIH’s National Center for Advancing Translational Sciences (NCATS) was a guest speaker. The workshop was open to all interested members of the scientific community and the public.

Pre-Workshop Discussions

In preparation for the workshop, invited participants held subgroup conference calls focused on the following four areas related to noise-induced synaptopathy: animal studies, human psychophysics, human electrophysiology, and mechanisms/therapies. During these calls, the subgroups delineated the current state of knowledge in these specific areas and began to identify knowledge gaps and barriers to filling those gaps. The subgroups also compiled a list of pertinent scientific articles to be read by all participants before the workshop. Subgroup conference calls were open to all invited workshop participants.

Workshop Format

The workshop (see agenda) began at 8 a.m. on May 4, 2015, with welcoming remarks from NIDCD Director James F. Battey, Jr., M.D., Ph.D., followed by introductory comments from Dr. Cyr. Dr. Liberman facilitated introductions of the invited workshop participants and Dr. Kujawa presented the workshop charge, which included a request to delineate a list of long-term and short-term research recommendations in the area of noise-induced cochlear synaptopathy. These workshop recommendations will help to guide NIDCD staff as well as the larger research community.

Dr. Tagle, NCATS, gave the first presentation, providing an overview of some of the challenges of translating animal studies to humans. Dr. Liberman then presented the current state of the auditory field regarding noise-induced synaptopathy in animal models and recent preliminary work demonstrating similar findings in human temporal bones. Each of the four subgroups then presented a synopsis of their pre-meeting discussions with an emphasis on the current state of scientific knowledge and the identified challenges, obstacles, and unanswered questions. Extensive group discussion followed each presentation as the panel members identified additional knowledge gaps and research needs.

Day two of the workshop began with additional whole-group discussions, followed by smaller breakout group discussions to generate specific research recommendations. The two breakout groups were:

  • Group 1 (Mechanisms and Potential Therapies): Drs. Glowatzki, Green, Kujawa, Liberman, and Lustig
  • Group 2 (Diagnostics): Drs. Brungart, Gallun, Heinz, Konrad-Martin, Lauer, McAlpine, Oxenham, Plack, and Shinn-Cunningham

Members of the audience were welcome to observe the breakout group discussions. When the breakout groups had developed a written list of recommendations, the entire workshop panel reconvened to discuss and refine the overall workshop recommendations. A draft of the workshop summary and recommendations was disseminated to workshop participants, who provided final input and edits.

Workshop Recommendations

The primary questions and research needs identified by the workshop panel are listed below. Recommendations were broken into subtopics and represent the discussions of the panel during the two-day workshop. The recommendations are not intended to be all-inclusive and are presented in no particular order.

Mechanisms and Potential Therapies for Noise-Induced Synaptopathy:

Primary Questions: Mechanisms

  • What are the mechanisms of normal pre- and post-synaptic transmission?
    • What are the pre-synaptic release mechanisms?
    • Which post-synaptic ion channels and pumps modulate afferent activity?
    • What are the differences underlying the properties of high- vs low-spontaneous rate fibers, and the molecular signals driving their developmental differentiation?
    • What is the basis of efferent modulation of dendritic activity—mechanisms of excitation and inhibition?
    • What are the special features of inner hair cell (IHC) synaptic transmission, and how do ribbon synapses differ across hair cell organs and vertebrate species?
  • What are the mechanisms of noise-induced cochlear synapse damage?
    • What is the phenomenology of primary neural degeneration?
      • What other cochlear insults lead to synaptopathy?
      • Do all TTS-inducing noise exposures produce synaptopathy; is synaptopathy worse when hair cells are also damaged; does impulse noise also cause synaptopathy? If impulse noise causes synaptopathy, is the mechanism the same as that for long exposures?
    • What are the dynamics of synapse damage—what is the sequence of structural and ultrastructural changes?
    • What are the receptor dynamics and trafficking in the post-synaptic bouton regarding postsynaptic receptors, especially NMDA-type and Ca2+-permeable AMPA-type receptors?
    • How is calcium homeostasis regulated in the post-synaptic bouton?
    • What are the roles of inflammatory processes, immune processes, and vascular changes in synaptopathy?
    • What are the contributions of glutamate excitotoxicity, recycling, and uptake in synaptopathy?
    • What is the role of reactive oxygen species and/or osmotic stress in synaptopathy?
    • Are there protective effects of prior noise exposure?
    • Do olivocochlear efferent fibers protect from synaptopathy?
  • What are the mechanisms of IHC synapse assembly and synapse regeneration?
    • Which signals drive the normal developmental process of IHC synapse assembly?
    • Is there IHC synapse reassembly after loss and what are the barriers to synapse reassembly in the adult cochlea?
    • Which neurotrophic factors support synaptogenesis and how are their synthesis and release affected by acoustic trauma?

Primary Questions: Potential Therapies

  • What are the in vitro requirements for neurite extension and synapse regeneration?
  • Can drug discovery identify small molecules that can rescue cochlear synaptopathy?
  • What is the therapeutic window (trauma-treatment interval) for in vivo neurotrophin-based synapse regeneration?
  • What is the functional status of neurotrophin-rescued synapses?
  • What is the permeability of the round window to drugs and viruses?
  • What is the efficacy of various slow-release polymers and hydrogels for drug/molecule delivery into the ear?
  • What is the efficacy of various viral vectors and promoters in targeting inner ear structures/cell types?

Technical and Infrastructure Needs

  • Utilize high-resolution calcium imaging of hair cell/auditory-nerve terminals synapses, e.g., with GCaMP, coupled with pharmacologic and genetic manipulation.
  • Implement/develop i) fast voltage and calcium sensors to monitor firing in auditory nerve fibers and ii) glutamate and pH detection methods to monitor IHC synaptic release in vitro.
  • Identify gene expression differences among the different spontaneous-rate spiral ganglion neuron groups to facilitate the development of cell-specific drivers for selective genetic silencing/activation of specific fiber types in vivo.
  • Develop minimally invasive in vivo imaging to visualize spiral ganglion cells, peripheral axons, synapses, etc., in animal models.
  • Standardize rigorous synaptic histological analyses across laboratories (e.g., core facilities/collaborative networks).

Diagnostics for Noise-Induced Synaptopathy:

Primary Questions: Diagnosis

  • What is the prevalence of noise-induced synaptopathy in humans?
  • Are there perceptual consequences of noise-induced synaptopathy? If so, what are they and how can they best be measured?
  • What is the most appropriate diagnostic test(s) for synaptopathy? What “gold standard” measure of synaptopathy should be used to determine the sensitivity and specificity of diagnostic tests?
  • Does noise-induced synaptopathy underlie patient-reported difficulties in understanding speech in noise in the absence of hearing loss?
  • Does noise-induced synaptopathy contribute to patient-reported difficulties in understanding speech in noise when hearing loss is also present?
  • What is the relationship between noise-induced synaptopathy and age-related hearing loss?
  • Is there a relationship between noise-induced synaptopathy and tinnitus?
  • What are the implications of noise-induced synaptopathy for noise exposure regulations?

To begin to answer these primary questions in the area of diagnostics, the panel considered the research needs, challenges, and approaches/considerations to address them in the areas of behavior, electrophysiology, modeling, and imaging:

Behavioral Studies
Needs and Identified Challenges:

  • Utilize animal behavior studies (informed by human psychoacoustics and computational modeling) for before and after comparisons following noise-induced synaptopathy.  Consider:
    • Interactions between noise exposure and aging (including the use of aging models).
    • Potential interactions between “pure” synaptopathy and threshold elevating pathologies.
    • Interactions of synaptopathy with other models of neural loss (e.g., ototoxic insults).
  • Utilize human psychoacoustics/speech studies to investigate noise-induced synaptopathy. Challenges with these studies include:
    • Minimizing inter-subject variability, including motivation, cognition, genetic heterogeneity, etc.
    • Interactions between age-related and noise-induced damage.

 Approaches and Considerations:

  • Behavioral tasks should consider:
    • Specificity of fiber loss (e.g. low- vs high-spontaneous fibers).
    • Potential effects of neural adaptation to sound statistics.
    • Characteristic frequency specificity.
    • Role of efferent fibers.
    • Relevance to speech understanding in challenging conditions.
    • Supra-threshold stimulation/testing.
    • Speech understanding in noise/babble.
    • Subjective measures include perceived hearing handicaps and listening effort.
    • Validation, sensitivity, specificity, and test/retest reliability.
  • Approaches include:
    • Longitudinal studies (military personnel, musicians, etc.).
    • Collections of large datasets—add to existing data banks or create new collections, such as using smartphone apps/mobile technology for testing pre-/post-concert attendance.
    • Increased use of human temporal bones:
      • Improve pre-mortem characterizations of the general health and hearing health of donors, including noise exposure and physical/ auditory test results, to enhance the study of pre-mortem auditory performance vs. post-mortem synaptopathy/histopathology.
      • Promote temporal bone donation programs to specific targeted populations—such as members of the military or musicians—who may have a history of auditory testing and increased likelihood of noise exposure.

Electrophysiology Studies
Needs and Identified Challenges:

  • Compare various electrophysiological measures for diagnosing synaptopathy.
  • Challenges include:
    • Individual differences
    • Mixed (sensory, neural) involvements
    • Consequences of peripheral damage on the central auditory system.

 Approaches and Considerations:

  • Optimize electrophysiological measures for sensitivity, specificity, time efficiency, test/re-test reliability, and validation. Potential measures for humans and animals include:
    • Frequency following response (monaural and binaural, modulation frequencies)
    • Auditory brainstem response (Wave I/ Wave V, amplitude, latency)
    • Middle ear muscle reflex
    • Medial olivocochlear bundle reflex
  • Use differential measures to reduce within- and between-subject variability.
  • Consider information contained within the responses (e.g., variability, not just mean responses).

Modeling Studies
Needs and Identified Challenges:

  • Employ computational modeling to make testable predictions for behavioral and physiological responses in animals and humans with synaptopathy, including speech and non-speech stimuli.

 Approaches and Considerations:

  • Use simple signal-detection (information) theory expectations as a baseline.
  • Extend to physiologically realistic models, including efferent effects, and potential differences between low- and high-spontaneous-rate fibers.
  • Extend the model to consider individuals who do not have a “pure” synaptopathy, but rather have mixed sensory and neural injuries.

Imaging Studies
Needs and Identified Challenges:

  • New/refined techniques for high-resolution, minimally invasive imaging of human auditory structures in vivo to detect damage at the cellular and subcellular level.

Approaches and Considerations:

  • Diffusion tensor imaging of auditory nerve
  • Fiber-optic tubes
  • Other magnetic resonance imaging/positron emission tomography techniques

Reading List Recommended and Read by Workshop Panel

Review Papers

Research studies:

Noise standards/regulations:

Primary Research Papers

Animal studies:

Human Electrophysiology and Human Psychophysics:

Optional:

Mechanisms/Therapies:

Optional:

Patient safety assistant

Check your symptom safely

Hi, I am RX Symptom Navigator. I can help you understand what to read next and what warning signs need care.
Warning: Do not use this in emergencies, pregnancy, severe illness, or as a substitute for a doctor. For children or teens, use with a parent/guardian and clinician.
A rural-friendly guide: warning signs, when to see a doctor, related articles, tests to discuss, and OTC safety education.
1 Symptom 2 Severity 3 Safe guidance
First safety question

Is there chest pain, breathing trouble, fainting, confusion, severe bleeding, stroke-like weakness, severe injury, or pregnancy danger sign?

Choose quickly

Browse by body area
Start here: Write or select a symptom. The guide will show warning signs, doctor guidance, diagnostic tests to discuss, OTC safety education, and related RX articles.

Important: This tool is educational only. It cannot diagnose, treat, or replace a doctor. OTC information is not a prescription. In an emergency, contact local emergency services or go to the nearest hospital.

Doctor visit helper

Prepare before seeing a doctor

A simple rural-patient checklist to help you explain symptoms clearly, ask better questions, and avoid unsafe self-treatment.

Safety note: This is not a prescription or diagnosis. For severe symptoms, pregnancy danger signs, children with serious illness, chest pain, breathing difficulty, stroke-like weakness, or major injury, seek urgent care.

Which doctor may help?

Start with a registered doctor or the nearest qualified health center.

What to tell the doctor

  • Write when the problem started and how it changed.
  • Bring old prescriptions, investigation reports, and current medicines.
  • Write allergies, pregnancy status, diabetes, kidney/liver disease, and major past illnesses.
  • Bring one family member if the patient is weak, elderly, confused, or a child.

Questions to ask

  • What is the most likely cause of my symptoms?
  • Which danger signs mean I should go to hospital quickly?
  • Which tests are necessary now, and which can wait?
  • How should I take medicines safely and what side effects should I watch for?
  • When should I come for follow-up?

Tests to discuss

  • Vital signs: temperature, pulse, blood pressure, oxygen saturation
  • Basic physical examination by a clinician
  • CBC, urine test, blood sugar, or imaging only when clinically needed

Avoid these mistakes

  • Do not use antibiotics, steroid tablets/injections, or strong painkillers without proper medical advice.
  • Do not hide pregnancy, kidney disease, ulcer, allergy, or blood thinner use.
  • Do not delay emergency care when danger signs are present.

Medicine safety and first-aid guide

This section is for patient education only. It does not replace a doctor, pharmacist, or emergency care.

Safe first steps

  • Avoid heavy lifting, sudden bending, and prolonged bed rest.
  • Use comfortable posture and gentle movement as tolerated.
  • Discuss physiotherapy, X-ray, or MRI only when clinically needed.

OTC medicine safety

  • For mild back pain, pain-relief medicine may be discussed with a doctor or pharmacist.
  • Avoid repeated painkiller use if you have kidney disease, stomach ulcer, uncontrolled blood pressure, or are taking blood thinners.

Avoid these mistakes

  • Do not start antibiotics without a proper medical decision.
  • Do not use steroid tablets or injections casually for quick relief.
  • Do not delay emergency care because of home remedies.

Get urgent help if

  • Back pain with leg weakness, numbness around private area, loss of urine/stool control, fever, cancer history, or major injury needs urgent care.
Medicine names, dose, and timing must be decided by a qualified clinician or pharmacist after checking age, pregnancy, allergy, other diseases, and current medicines.

For rural patients and family caregivers

Patient health record and symptom diary

Write your symptoms, medicines already taken, test results, and questions before visiting a doctor. This note stays on your device unless you print or copy it.

Doctor to discuss: Doctor / qualified healthcare provider
Tests to discuss with doctor
  • Basic vital signs: temperature, pulse, blood pressure, oxygen level if needed
  • Relevant blood, urine, imaging, or specialist tests only after clinical assessment
Questions to ask
  • What is the most likely cause of my symptoms?
  • Which warning signs mean I should go to emergency care?
  • Which tests are really needed now?
  • Which medicines are safe for my age, pregnancy status, allergy, kidney/liver/stomach condition, and current medicines?

Emergency warning signs such as chest pain, severe breathing difficulty, sudden weakness, confusion, severe dehydration, major injury, or loss of bladder/bowel control need urgent medical care. Do not wait for online information.

Safe pathway to proper treatment

Back pain care roadmap

Use this simple roadmap to understand the next safe steps. It is educational and does not replace examination by a doctor.

Go to emergency care if you notice:
  • New leg weakness, numbness around private area, or loss of bladder/bowel control
  • Back pain after major injury, fever, unexplained weight loss, cancer history, or severe night pain
Doctor / service to discuss: Orthopedic/spine specialist, physical medicine doctor, physiotherapist under guidance, or qualified clinician.
  1. Step 1

    Check danger signs first

    If danger signs are present, seek emergency care and do not wait for online information.

  2. Step 2

    Record the symptom story

    Write when symptoms started, severity, medicines already taken, allergies, pregnancy status, and test results.

  3. Step 3

    Visit a qualified clinician

    A doctor, nurse, or qualified healthcare provider can examine you and decide which tests or treatment are needed.

  4. Step 4

    Do only useful tests

    Discuss neurological examination first. X-ray or MRI may be needed only when red flags, injury, nerve weakness, or persistent severe symptoms are present.

  5. Step 5

    Follow up and return early if worse

    If symptoms worsen, new warning signs appear, or treatment is not helping, return for review quickly.

Rural patient practical tips
  • Take a written symptom diary and all previous prescriptions/test reports.
  • Do not hide medicines already taken, even herbal or over-the-counter medicines.
  • Ask which warning signs mean urgent referral to hospital.
  • Avoid forceful massage or bone-setting when there is weakness, injury, fever, or nerve symptoms.

This roadmap is for education. A real diagnosis and treatment plan requires history, examination, and clinical judgment.

RX Patient Help

Ask a health question safely

Write your symptom story. A health professional or site editor can review it before any answer is prepared. This box is not for emergency care.

Emergency first: Severe chest pain, breathing trouble, unconsciousness, stroke signs, severe injury, heavy bleeding, or rapidly worsening symptoms need urgent local medical care now.

Frequently Asked Questions

Is this article a replacement for a doctor?

No. It is educational content only. Patients should consult a qualified clinician for diagnosis and treatment.

When should I seek urgent care?

Seek urgent care for severe symptoms, rapidly worsening condition, breathing difficulty, severe pain, neurological changes, or any emergency warning sign.

References

Add references, clinical guidelines, textbooks, journal articles, or trusted medical sources here. You can edit this area from the RX Article Professional Blocks panel.